Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cyclohexenones via Michael Addition and Aldol Condensation: The Robinson Annulation01:27

Cyclohexenones via Michael Addition and Aldol Condensation: The Robinson Annulation

2.5K
Robinson annulation is a base-catalyzed reaction for the synthesis of 2-cyclohexenone derivatives from 1,3-dicarbonyl donors (such as cyclic diketones, β-ketoesters, or β-diketones) and α,β-unsaturated carbonyl acceptors. Named after Sir Robert Robinson, who discovered it, this reaction yields a six-membered ring with three new C–C bonds (two σ bonds and one π bond).
2.5K
[3,3] Sigmatropic Rearrangement of Allyl Vinyl Ethers: Claisen Rearrangement01:24

[3,3] Sigmatropic Rearrangement of Allyl Vinyl Ethers: Claisen Rearrangement

2.4K
The Claisen rearrangement is a [3,3] sigmatropic rearrangement of allyl vinyl ethers to unsaturated carbonyl compounds. The rearrangement is a concerted pericyclic reaction proceeding via a chair-like transition state.
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enantioselective Radical Cascade Cyclization to Axially Chiral Medium-Sized Lactones.

Angewandte Chemie (International ed. in English)·2026
Same author

Distribution of the high-quality suitable areas of <i>Ligusticum chuanxiong</i> in Sichuan Province, China based on component-environment coupling.

Ying yong sheng tai xue bao = The journal of applied ecology·2026
Same author

Photo-induced terminal alkyne insertion into arene ring to synthesize boron-doped polycycles.

Chemical science·2026
Same author

Studies toward Total Synthesis of Cipadonoid A and Harpertrioate A via Radical Cyclization.

The Journal of organic chemistry·2026
Same author

Ligand-Regulated Metallaphotoredox Aminoarylation for the Valorization of Feedstock Alkenes.

Journal of the American Chemical Society·2026
Same author

Machine Learning Inverse Design Reveals a Double Narrow-Band Absorption Approach for Effective Colored Radiative Cooling Paints.

Nano letters·2026

Related Experiment Video

Updated: Nov 9, 2025

Accessing Valuable Ligand Supports for Transition Metals: A Modified, Intermediate Scale Preparation of 1,2,3,4,5-Pentamethylcyclopentadiene
09:45

Accessing Valuable Ligand Supports for Transition Metals: A Modified, Intermediate Scale Preparation of 1,2,3,4,5-Pentamethylcyclopentadiene

Published on: March 20, 2017

10.7K

Semisynthesis of CRV431.

Feng-Xia Li1, Qing-Zhou Zhang1, Shi-Jun Li2

  • 1State Key Laboratory of Chemical Oncogenomics and Laboratory of Chemical Genomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen 518055, China.

Organic Letters
|April 12, 2021
PubMed
Summary

CRV431, a non-immune-suppressive cyclophilin inhibitor, shows promise for treating nonalcoholic steatohepatitis (NASH), liver fibrosis, and cancer. A new four-step chemical semisynthesis makes this potential therapeutic more accessible.

More Related Videos

Synthesis of a Thiol Building Block for the Crystallization of a Semiconducting Gyroidal Metal-sulfur Framework
12:30

Synthesis of a Thiol Building Block for the Crystallization of a Semiconducting Gyroidal Metal-sulfur Framework

Published on: April 9, 2018

9.3K
Nanosponge Tunability in Size and Crosslinking Density
11:15

Nanosponge Tunability in Size and Crosslinking Density

Published on: August 4, 2017

7.8K

Related Experiment Videos

Last Updated: Nov 9, 2025

Accessing Valuable Ligand Supports for Transition Metals: A Modified, Intermediate Scale Preparation of 1,2,3,4,5-Pentamethylcyclopentadiene
09:45

Accessing Valuable Ligand Supports for Transition Metals: A Modified, Intermediate Scale Preparation of 1,2,3,4,5-Pentamethylcyclopentadiene

Published on: March 20, 2017

10.7K
Synthesis of a Thiol Building Block for the Crystallization of a Semiconducting Gyroidal Metal-sulfur Framework
12:30

Synthesis of a Thiol Building Block for the Crystallization of a Semiconducting Gyroidal Metal-sulfur Framework

Published on: April 9, 2018

9.3K
Nanosponge Tunability in Size and Crosslinking Density
11:15

Nanosponge Tunability in Size and Crosslinking Density

Published on: August 4, 2017

7.8K

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Hepatology

Background:

  • Nonalcoholic steatohepatitis (NASH) is a progressive liver disease with significant unmet medical needs.
  • CRV431 is a novel, non-immune-suppressive cyclophilin inhibitor with demonstrated potential in treating NASH, liver fibrosis, and reducing cancer incidence.
  • Existing synthetic routes may limit the accessibility of CRV431 for further clinical development.

Purpose of the Study:

  • To develop a concise and efficient chemical semisynthesis of the therapeutic candidate CRV431.
  • To establish a scalable synthetic route from a readily available starting material.

Main Methods:

  • A four-step semisynthesis of CRV431 was designed starting from commercially available cyclosporine.
  • Key transformations included flow-chemistry-based methylenation, intermolecular ring-closing metathesis, and Rh-catalyzed diastereoselective hydrogenation.

Main Results:

  • A concise four-step semisynthesis of CRV431 was successfully achieved.
  • The synthetic route utilizes key modern organic chemistry techniques, including flow chemistry and metal catalysis.
  • This streamlined synthesis enhances the accessibility of CRV431 for further research and clinical application.

Conclusions:

  • The developed semisynthesis provides an efficient and accessible route to CRV431.
  • This advancement supports the further clinical investigation of CRV431 as a potential treatment for NASH, liver fibrosis, and associated cancers.